{"id":56934,"date":"2017-03-08T07:34:57","date_gmt":"2017-03-08T12:34:57","guid":{"rendered":"http:\/\/www.hedgeco.net\/news\/?p=56934"},"modified":"2017-03-08T07:34:57","modified_gmt":"2017-03-08T12:34:57","slug":"hedge-fund-sarissa-seeks-to-replace-majority-of-innovivas-board","status":"publish","type":"post","link":"https:\/\/hedgeco.net\/news\/03\/2017\/hedge-fund-sarissa-seeks-to-replace-majority-of-innovivas-board.html","title":{"rendered":"Hedge Fund Sarissa Seeks to Replace Majority of Innoviva&#8217;s Board"},"content":{"rendered":"<p>(Reuters) Innoviva Inc said activist investor Sarissa Capital Management LP had nominated four directors to replace a majority of the drug company&#8217;s board.<\/p>\n<p>The company&#8217;s shares were up 3.1 percent at $12 in early trading on Tuesday.<\/p>\n<p>Innoviva, formerly Theravance Inc, urged shareholders to vote for its recommended seven nominees at the 2017 annual meeting.<\/p>\n<p>To read this article, <a href=\"http:\/\/www.reuters.com\/article\/us-innoviva-sarissa-idUSKBN16E1QS\">click here.\u00a0<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Reuters) Innoviva Inc said activist investor Sarissa Capital Management LP had nominated four directors to replace a majority of the drug company&#8217;s board. The company&#8217;s shares were up 3.1 percent at $12 in early trading on Tuesday. Innoviva, formerly Theravance [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-56934","post","type-post","status-publish","format-standard","hentry","category-syndicated"],"_links":{"self":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/56934","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/comments?post=56934"}],"version-history":[{"count":1,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/56934\/revisions"}],"predecessor-version":[{"id":56935,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/56934\/revisions\/56935"}],"wp:attachment":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/media?parent=56934"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/categories?post=56934"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/tags?post=56934"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}